Expert: Pharmacy, Medical Benefit Adoption of Biosimilars Present Different Challenges
May 2nd 2023Fran Gregory, PharmD, MBA, vice president of Emerging Therapies at Cardinal Health, discussed the biosimilars landscape and where biosimilars fall in the process of pharmacy and medical benefit adoption.
Watch
Changing the Game: Pharmacy Students' Perspective on Naloxone OTC Approval
To eliminate the existing stigma in the community, addiction must be recognized as a treatable condition rather than an immoral act.
Read More